Both glibenclamide and riluzole reduce necrosis and improve outcome in rat models of spinal cord injury (SCI). In SCI, gene suppression experiments...
Array
(
[id_prestablog_news] => 366
[id_shop] => 1
[date] => 2012-01-08 00:00:00
[date_modification] => 2024-02-09 14:15:11
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 728
[id_lang] => 2
[title] => Comparative effects of glibenclamide and riluzole in a rat model of severe cervi
[paragraph] => Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.
[content] => Authors
M. Simard, O. Tsymbalyuk, K. Keledjian, A. Ivanov, S. Ivanova et al.
Lab
University of Maryland School of Medicine, Department of Neurosurgery, Baltimore, USA.
Journal
Experimental Neurology
Abstract
Both glibenclamide and riluzole reduce necrosis and improve outcome in rat models of spinal cord injury (SCI). In SCI, gene suppression experiments show that newly upregulated sulfonylurea receptor 1 (Sur1)-regulated NC(Ca-ATP) channels in microvascular endothelial cells are responsible for persistent sodium currents that cause capillary fragmentation and progressive hemorrhagic necrosis. Glibenclamide is a potent blocker of Sur1-regulated NC(Ca-ATP) channels (IC(50), 6-48 nM). Riluzole is a pleotropic drug that blocks persistent sodium currents in neurons, but in SCI, its molecular mechanism of action is uncertain. We hypothesized that riluzole might block the putative pore-forming subunits of Sur1-regulated NC(Ca-ATP) channels, Trpm4. In patch clamp experiments, riluzole blocked Sur1-regulated NC(Ca-ATP) channels in endothelial cells and heterologously expressed Trpm4 (IC(50), 31 _M). Using a rat model of cervical SCI associated with high mortality, we compared the effects of glibenclamide and riluzole administered beginning at 3h and continuing for 7 days after impact. During the acute phase, both drugs reduced capillary fragmentation and progressive hemorrhagic necrosis, and both prevented death. At 6 weeks, modified (unilateral) Basso, Beattie, Bresnahan locomotor scores were similar, but measures of complex function (grip strength, rearing, accelerating rotarod) and tissue sparing were significantly better with glibenclamide than with riluzole. We conclude that both drugs act similarly, glibenclamide on the regulatory subunit, and riluzole on the putative pore-forming subunit of the Sur1-regulated NC(Ca-ATP) channel. Differences in specificity, dose-limiting potency, or in spectrum of action may account for the apparent superiority of glibenclamide over riluzole in this model of severe SCI.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
[meta_description] =>
[meta_keywords] => http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272255/?tool=pubmed
[meta_title] =>
[link_rewrite] => comparative-effects-of-glibenclamide-and-riluzole-in-a-rat-model-of-severe-cervical-spinal-cord-injury--
[actif_langue] => 1
[read] => 1012
[count_comments] => 0
[id] => 366
[categories] => Array
(
[39] => Array
(
[id_prestablog_categorie] => 39
[title] => Moelle épinière
[link_rewrite] => Moelle-epiniere
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
[11] => Array
(
[id_prestablog_categorie] => 11
[title] => Système Nerveux Central (SNC)
[link_rewrite] => Systeme-Nerveux-Central-SNC
)
)
[authors] =>
[paragraph_crop] => Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal [...]
[link_for_unique] => 1
[products_liaison] => Array
(
[48] => Array
(
[name] => Test d'agrippement
[description_short] => Une méthode simple pour quantifier objectivement la force musculaire des rats et souris et l'effet de drogues, toxines, maladies musculaires (ex: myopathie) et neurodégénératives. Cette mesure de force est souvent employée en association avec le test de coordination motrice ROTAROD: un sujet présentant une coordination normale montrera des résultats médiocres en cas de faible force musculaire. Un must pour vos recherches sur l'activité, la coordination et le contrôle musculaire: particulièrement utile pour vos études sur les maladies de Parkinson et Huntington.
Nouveautés GS4 - 2023: Écran couleur rétroéclairé (meilleure lisibilité), pédale de remise à zéro, durée de batterie optimisée, taille de mémoire augmentée à 500 valeurs, compteur d'animaux, port USB (transfert de données/charge)


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/fr/activite-systeme-moteur-coordination/48-grip-strength-test.html
)
)
)
1 En lire plus